 |
Serotonin Uptake Inhibitors - Therapeutic use
Research News and Information
Definition of 'Serotonin Uptake Inhibitors'Compounds that specifically inhibit the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent. These agents have been used in treatment of depression, panic disorder, obsessive-compulsive behavior, and alcoholism, as analgesics, and to treat obesity and bulimia. Many of the ADRENERGIC UPTAKE INHIBITORS also inhibit serotonin uptake; they are not included here. |
Thursday, March 18, 2010
[Narcolepsy and other hypersomnias]
6 Oct 2009 
BACKGROUND: Narcolepsy is currently categorized into three groups; narcolepsy with and without emotionally triggered loss of muscle tone (cataplexy), and narcolepsy secondary to other medical conditions. Many patients with hypersomnia are diagnosed ... Read more...
Treatment of neuropathic pain: an overview of recent guidelines.
29 Sep 2009 A number of different treatments for neuropathic pain have been studied, but the literature is sizable, rapidly evolving, and lacks important information about practical aspects of patient management. Under the auspices of the International ... Read more...
Pharmacotherapy for depressed pregnant women: overcoming obstacles to gathering essential data.
29 Sep 2009 Approximately 3% of pregnant women take antidepressant medications. Information on the impact of antidepressants on short- and long-term maternal and offspring outcomes is highly desirable but neglected. The position that the dearth of treatment ... Read more...
Latest indexed articles for 'Serotonin Uptake Inhibitors - Therapeutic use'
These are the very latest articles for this heading:
- Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression.
30 Oct 2009 - [Narcolepsy and other hypersomnias] 6 Oct 2009
- Drug fails to subdue repetitive behavior in children with autism spectrum disorders. 29 Sep 2009
- Treating premenstrual dysphoric disorder. Options include drugs targeting serotonin and various types of hormone therapy. 29 Sep 2009
- Antidepressant use and preterm birth. 29 Sep 2009
- Treatment of neuropathic pain: an overview of recent guidelines. 29 Sep 2009
- Pharmacotherapy for depressed pregnant women: overcoming obstacles to gathering essential data. 29 Sep 2009
- Benefits exceed risks of newer antidepressant medications in youth--maybe not. 29 Sep 2009
- Benefits exceed risks of newer antidepressant medications in youth--maybe. 29 Sep 2009
- Probable fluoxetine-induced carotidynia. 24 Sep 2009
- [Pharmaceutical treatment of cancer-associated fatigue--a survey of a Cochrane review] 19 Sep 2009
- Randomized, controlled clinical trial of the efficacy of fluoxetine for treatment of compulsive disorders in dogs. 13 Sep 2009
- Antidepressant medication use during breastfeeding. 30 Aug 2009
- [Observation on effective characteristics of acupuncture combined with medicine on depression of different syndrome types] 30 Aug 2009
- Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. 30 Aug 2009
- The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up. 30 Aug 2009
- Clinical messages from the Treatment for Adolescents With Depression Study (TADS). 30 Aug 2009
- Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients. 30 Aug 2009
- Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study. 30 Aug 2009
- Treating bulimia nervosa. A combination of cognitive behavioral therapy and medication works best. 30 Aug 2009
See a longer list of these articles.
Technical information about 'Serotonin Uptake Inhibitors'
Definition: Compounds that specifically inhibit the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent. These agents have been used in treatment of depression, panic disorder, obsessive-compulsive behavior, and alcoholism, as analgesics, and to treat obesity and bulimia. Many of the ADRENERGIC UPTAKE INHIBITORS also inhibit serotonin uptake; they are not included here.
Registry Number: 0
Descriptor UI: D017367
Alternative terms: Serotonin Uptake Inhibitors; Uptake Inhibitors, 5-HT; Uptake Inhibitors, 5 HT; 5-HT Uptake Inhibitors; 5 HT Uptake Inhibitors; Inhibitors, 5-Hydroxytryptamine Uptake; Inhibitors, 5 Hydroxytryptamine Uptake; Uptake Inhibitors, 5-Hydroxytryptamine; Uptake Inhibitors, 5 Hydroxytryptamine; Inhibitors, Serotonin Reuptake; Reuptake Inhibitors, Serotonin; Serotonin Reuptake Inhibitors; Inhibitors, Serotonin Uptake; Uptake Inhibitors, Serotonin; Inhibitors, 5-HT Uptake; Inhibitors, 5 HT Uptake; 5-Hydroxytryptamine Uptake Inhibitors; 5 Hydroxytryptamine Uptake Inhibitors;
Related Mesh Headings: Antidepressive Agents, Second-Generation; Adrenergic Uptake Inhibitors;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Tree Number: D27.505.519.625.600.850; D27.505.519.625.850.900; D27.505.696.577.600.850; D27.505.696.577.850.900;
History Note: 93
Technical Notes: GEN or unspecified; prefer specifics; do not confuse with SEROTONIN ANTAGONISTS; DF: SEROTONIN UPTAKE INHIB